Gregory Springsted

Gregory R. Springsted — Patent Litigation Practice Summary

Practice focus and side mix. Springsted's patent work spans two distinct areas: Hatch-Waxman/ANDA pharmaceutical litigation (his Kirkland & Ellis years) and plaintiff-side patent enforcement for monetization entities in consumer-electronics and software/tech cases (his Schulte Roth & Zabel and Stroock & Stroock years). Tracked appearances skew plaintiff-side (2 plaintiff, 1 defendant), and that pattern holds in his web-verified docket work: he appeared pro hac vice for plaintiffs in Multimedia Technologies Pte. Ltd. v. Vizio, Inc. (E.D. Tex., Wi-Fi standards patents), Multifold International v. Samsung (E.D. Tex.), Geoscope Technologies v. Google (E.D. Va.), and Kewazinga Corp. v. Microsoft (S.D.N.Y.). At Kirkland he worked both sides of pharma disputes — representing ANDA filers Actavis/Teva and brand-side Novartis in related matters — so his practice is genuinely bilateral, with current NPE-side emphasis.

Firm context. Springsted is special counsel in Schulte Roth & Zabel's Litigation group in New York, a role he took in April 2023 when he moved with the Tim Gilman/Chris Gerson team (SRZ's announcement identifies him as part of that group, and he was promoted to special counsel in January 2024). He previously practiced at Kirkland & Ellis (New York) on pharmaceutical patent matters and at Stroock & Stroock & LaVan.

Notable matters and PTAB experience. His most prominent tracked matter is Actavis Elizabeth LLC v. Novartis AG (D. Del., ANDA case over U.S. Patent No. 9,283,209; terminated 2018), tied to IPR2017-01946, in which he served as pro hac vice counsel for petitioners Actavis and Teva against Novartis's S1P-receptor-modulator patent (U.S. 9,187,405) — a proceeding joined with IPR2017-00854 and resolved by final written decision in August 2018. He also worked on Impax Laboratories v. Actavis Laboratories (D.N.J., ANDA) and Novartis Pharmaceuticals Corp. v. Teva Pharmaceuticals USA (defense side). He appears regularly in PTAB practice on both sides: petitioner-side in IPR2017-01946 and patent-owner-side in the LG/Vizio IPRs (IPR2024-00351/-00352/-00354 and IPR2024-00694/-00696/-00699) challenging Multimedia Technologies' Wi-Fi patents. He also co-authored a chapter on patent issues in cell and gene therapy products (PLI, Pharmaceutical and Biotech Patent Law, 2023).

Education. J.D., New York University School of Law; B.S., University of Richmond (per SRZ's January 2024 announcement). Bar admissions were not confirmed in the sources reviewed and are omitted.